A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)

NCT07501559 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Glioblastoma Multiforme(GBM)

Interventions

BIOLOGICAL: JL15003Injection

Sponsor

Jecho Biopharmaceuticals Co., Ltd.